DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
activeFounded 2011

Synthace

HQ: London, UKCEO: Markus GershaterHeadcount: 80+synthace.com
Funding Summary
Total Funding
$60M+
Latest Valuation
Undisclosed
About

Antha platform for visual experiment design and execution using DOE principles, improving reproducibility in synbio and biopharma workflows.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →